Xone Ceff S 500mg/250mg Injection
Marketer
Lupin Ltd
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Xone Ceff S 500mg/250mg Injection
Cefixime and Sulbactam injection (500mg/250mg), marketed as Xone Ceff S, combats bacterial infections by inhibiting microbial growth. Administered only by a healthcare provider, this dual-action medication requires adherence to the prescribed dosage schedule. Complete the full treatment course, even with symptom improvement, to prevent treatment failure. Discontinuing prematurely may reduce efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; contact your physician if these worsen. Seek immediate medical attention for allergic reactions such as rashes, itching, swelling, or respiratory distress. Inform your doctor about all current medications, including those for pre-existing conditions, before commencing treatment. Pregnant or lactating individuals should consult their doctor. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing, driving should be avoided if drowsiness or dizziness occur. Rest, proper nutrition, and adequate hydration promote faster recovery. Your doctor may order blood tests and other diagnostic procedures to monitor treatment response.
Primary Ingredients of Xone Ceff S 500mg/250mg Injection
No text provided. Please provide the text you want me to rephrase.
Uses of Xone Ceff S 500mg/250mg Injection
Infections caused by bacteria
Major Benefits of Xone Ceff S 500mg/250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Xone Ceff S 500mg/250mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Xone Ceff S 500mg/250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
How Xone Ceff S 500mg/250mg Injection works:
The injectable formulation Xone Ceff S (500mg/250mg) unites Ceftriaxone, an antibiotic, with Sulbactam, a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Sulbactam counters bacterial resistance mechanisms, thereby boosting Ceftriaxone's antibacterial effectiveness.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Xone Ceff S 500mg/250mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Xone Ceff S (500mg/250mg) is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; however, data from human trials are scarce.
Breast feedingCAUTION
The administration of Xone Ceff S 500mg/250mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's course of treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Xone Ceff S 500mg/250mg Injection may induce drowsiness, visual disturbances, or dizziness. Driving should be avoided if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Xone Ceff S 500mg/250mg Injection to individuals with renal impairment. Physician consultation is recommended.
LiverCAUTION
Exercise caution when administering Xone Ceff S 500mg/250mg Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alterations for Xone Ceff S 500mg/250mg Injection are not advised for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Xone Ceff S 500mg/250mg Injection :
Should you inadvertently skip a dose of Xone Ceff S 500mg/250mg Injection, seek medical advice immediately.
Facts to Know About Xone Ceff S 500mg/250mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-infective agents |









